share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Arcutis Biotherapeutics | 4：持股變動聲明-高管 Matsuda Masaru
美股sec公告 ·  05/04 04:29
牛牛AI助理已提取核心訊息
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 5,016 shares of common stock on May 2, 2024. The transaction was executed at a price of $8.7378 per share, resulting in a total sale value of approximately $43,828.80. Following the sale, Matsuda Masaru's direct holdings in the company amount to 185,408 shares. The sale took place in an open market or private sale, as per the transaction code description.
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 5,016 shares of common stock on May 2, 2024. The transaction was executed at a price of $8.7378 per share, resulting in a total sale value of approximately $43,828.80. Following the sale, Matsuda Masaru's direct holdings in the company amount to 185,408 shares. The sale took place in an open market or private sale, as per the transaction code description.
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的松田勝於2024年5月2日完成了5,016股普通股的出售。該交易以每股8.7378美元的價格執行，總銷售價值約爲43,828.80美元。出售後，松田勝在該公司的直接持股量爲185,408股。根據交易代碼描述，此次出售是在公開市場或私人銷售中進行的。
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的松田勝於2024年5月2日完成了5,016股普通股的出售。該交易以每股8.7378美元的價格執行，總銷售價值約爲43,828.80美元。出售後，松田勝在該公司的直接持股量爲185,408股。根據交易代碼描述，此次出售是在公開市場或私人銷售中進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。